Myeloid Leukemia
Research from Harvard University provide new insights into myeloid leukemia
Published in Hematology Week, February 15th, 2010
"Cytogenetic testing at diagnosis yields critical prognostic information, but more refinement in prognosis is required," wrote R.M. Stone and colleagues, Harvard University.
The researchers concluded: "Within cytogenetic subgroups, further important subgroup definitions are possible based on the mutation status and expression analysis of genes such as C-KIT, FLT3, NPM1 and CEBPA, although defining therapies based on such mutations remains...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hematology Week
Source: Hematology Week (2010-02-15)
More Articles from Hematology Week
- American Academy of Neurology
Recent immigrants may have lower risk of early stroke - Columbia University Medical Center
Crucial differences found among Latino populations facing heart disease risks - Columbia University Medical Center
Even small dietary reductions in salt could mean fewer heart attacks, strokes and deaths - Johns Hopkins Medical Institutions
3 years out, safety checklist continues to keep hospital infections in check - Stowers Institute for Medical Research
Linheng Li proposes novel theory for mammalian stem cell regulation - Wiley-Blackwell
Heart attack victims who have ECGs in the field experience shorter time-to-treatment - More from this issue of Hematology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
